Phani Surapaneni, MD
Basic profileLouisiana State University Health Sciences Center Shreveport
Phani Surapaneni is a Cardiology physician affiliated with Louisiana State University Health Sciences Center Shreveport. OpenAlex indexes 56 publications with 547 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1541 Kings Hwy
Shreveport, LA 711034228
Telephone
318-626-0000Provider last certified this registry record 14 Mar 2023.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20246 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.7%Beta blocker20.3%Metoprolol Tartrate43%Metoprolol Succinate33%Carvedilol24%Part D<11 patientsAldosterone antagonist (MRA)16.1%Spironolactone100%Part D≥12 patients+ 4 more classes in this area
Metabolism & gastrointestinal
23.8%SGLT2 inhibitor23.8%Jardiance100%Part D≥13 patientsBlood & clotting
4.5%Factor Xa inhibitor4.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-19073-ACC ASSOCIATION BETWEEN BICUSPID AORTIC VALVE AND SHORT-TERM OUTCOMES IN PREGNANT WOMEN
Journal of the American College of Cardiology
2026 - 26-A-18966-ACC IMPACT OF PREGNANCY ON LONG-TERM OUTCOMES IN WOMEN WITH BICUSPID AORTIC VALVE
Journal of the American College of Cardiology
2026 - OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION IN HYPERTROPHIC CARDIOMYOPATHY: A PROPENSITY-MATCHED NATIONAL STUDY
Journal of the American College of Cardiology
2024 - SHORT-TERM OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH CONCOMITANT MITRAL REGURGITATION
Journal of the American College of Cardiology
2024 - DEMOGRAPHIC, ETHNIC, AND REGIONAL TRENDS IN CRITICAL LIMB ISCHEMIA-RELATED HOSPITALIZATIONS IN US (2008-2020)
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Sami Bahna, MD
Louisiana State University Health Sciences Center Shreveport
Terry Lairmore, MD
Louisiana State University Health Sciences Center Shreveport
Robert Henning, MD
Louisiana State University Health Sciences Center Shreveport
Roger Kelley, MD
Louisiana State University Health Sciences Center Shreveport
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”